Featured Abstracts and Author Insights

*EMBARGOED All research presented at the 2019 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 28, 2019, at 8:00 am CDT.

---

Newsworthy Abstracts Highlight Cutting-Edge Clinical GI Science

This page is a gateway to explore the clinical GI science featured at the 2019 ACG Annual Scientific Meeting. Here you will find award-winning abstracts, commentary and perspective from select authors of newsworthy findings, and tips to navigate the array of clinical research being presented at ACG 2019 by investigators working to advance digestive health and improve patient care.

The authors of ACG’s Newsworthy Abstracts, selected by the ACG Public Relations Committee, provide additional perspective on their findings and explain what the clinical science means for patients. Following the links below, reporters can explore these Newsworthy Abstracts and author insights and connect with these researchers for media stories. To review all ACG Press Releases, visit Media Statements.

• Final Program Book for ACG 2019 Annual Scientific Meeting
  • The Final Program Book, which is distributed onsite at the meeting, contains information for the Plenary Session oral papers, some of the major science being presented at the meeting.
• ACG 2019 Itinerary Planner
  • Tip: the online itinerary planner will help you access the full text of the abstracts. Check back this summer to learn more about signing up for and using the itinerary planner.
• Award-Winning Abstracts
  • ACG’s Presidential Posters are highly meritorious projects selected by the Educational Affairs Committee, and the College recognizes excellent clinical research by organ-system category as well as research by fellows-in-training.
• Newsworthy Abstracts
  • Explore some of the papers and presentations selected by reviewers from ACG’s Educational Affairs and Public Relations Committees, a distinguished group of experts who suggested papers and posters with innovative, newsworthy, and/or significant findings.

Nominated by the ACG Public Relations Committee, this group of abstracts features scientific findings that are innovative, newsworthy for the lay reader, relevant to those who suffer from common GI problems, and which represent a significant advancement in the diagnosis and treatment of GI diseases. The Committee aims to identify novel and thought-provoking abstracts which reinforce key public health messages, such as the importance of colorectal cancer screening (particularly for minority and at-risk populations), or which feature common GI problems in a new way.

• Oral 1 Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled Trial; Ikuo Hirano, MD, FACG
• Oral 3 Transitioning From Vedolizumab IV to Vedolizumab SC in Patients With Ulcerative Colitis: Results From the VISIBLE Program; Douglas Wolf, MD, FACG
• Oral 6 Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-analysis and Systematic Review, Muhammad Talal Sarmini, MD
• Oral 16 Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography: Performance Ratings From a Case Series of 60 Patients; V. Raman Muthusamy, MD, MAS, FACG
• Oral 18 Are All Endoscopic-Related Musculoskeletal Injuries Created Equal?: Results of a National Gender-Based Survey; Swati Pawa, MD, FACG
• Oral 25 Prevalence of Advanced Polyps at Age 45-49 Is Similar to 50-54 Years; Lynn F. Butterly, MD
• Oral 34 Cumulative Increase in the Prevalence of Esophageal Cancer in Patients With Gastroesophageal Reflux Disease (GERD) and Multiple Risk Factors; Omar A. Alaber, MD
• Oral 38 Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory Disorders of the Ileal Pouch; Hamna Fahad, MD, MBBS
• Oral 59 Incidence of Venous Thromboembolic Events in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Clinical Development Program; William J. Sandborn, MD, FACG
• Oral 68 Single Day Low Residue Diet Prior to Colonoscopy Shows Improved Bowel Preparation Quality and Patient Tolerance Over Clear Liquid Diet: Final Results From a Randomized, Single-Blinded, Dual Center Study; Nabil El Hage Chehade, MD
• Oral 72 Impact of Weight Parameters on Colorectal Cancer Survival: A Systematic Review and Meta-Analysis; Vita Jaspan, BA
• P0012 Outcomes of Acute Necrotizing Pancreatitis and Associated Fluid Collections in Cannabis Users; C. Roberto Simons-Linares, MD, MSc
• P0015 Association Between Acute Pancreatitis and Cannabis Use – A U.S. Population-Based Study; Saad Saleem, MD
• P0288 Opioids Interfere With Deglutitive Inhibition Assessed by Response to Multiple Rapid Swallows During High; Diana L. Snyder, MD
• P0359 Developing and Validating a Prediction Model to Identify Patients at High Risk for Failing Standard Sedation for Routine GI Endoscopy; Megan A. Adams, MD, JD, MSc
• P1522 Fibroscan Is a Feasible and Useful Point-Of-Care Tool to Assess Nonalcoholic Fatty Liver Disease Severity in Children Texas Liver Institute, University of Texas (UT) Health San Antonio, San Antonio, TX; Oladuni D. Cummings-John, MD
• P1551 The Prevalence of Liver Fibrosis in Hispanic Adolescents With Nonalcoholic Fatty Liver Disease Is High and Independent of the Presence of Prediabetes and Diabetes; Sanjeet Sandhu, DO
• P1916 Caffeine Consumption and the Colonic Mucosa-Associated Gut Microbiota; Li Jiao, MD, MS, PhD
• P2035 “Go Before You Go”: Interim Analysis of a Quality Improvement Project to Improve Colorectal Cancer Screening in a Safety Net Primary Care Clinic; Shida Haghighat, MD, MPH
• P2061 When Crime Does Pay: How a Stolen Colon Went Viral and Raised Global Screening Awareness; Erin Peterson